Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
influenza virus split vaccine + BK-01 adjuvant
- Development stage
- Unknown
- Lead developer
- Changchun BCHT Biotechnology
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Influenza virus split vaccine + BK-01 adjuvant is an adjuvanted split-virion influenza vaccine developed by Changchun BCHT Biotechnology for the prevention of influenza. The vaccine combines inactivated split influenza virus antigens with BCHT's proprietary BK-01 adjuvant, which is designed to enhance immunogenicity, particularly in older adults aged 60 and above. The vaccine is formulated as both trivalent and quadrivalent split-virus preparations. It is currently in Phase I clinical development in China.
- Other names
- Split Influenza Vaccine with BK-01 Adjuvantinfluenza virus split vaccine (BK-01 adjuvant)quadrivalent influenza virus split vaccine (BK-01 adjuvant)trivalent influenza virus split vaccine (BK-01 adjuvant)
02
Targets
HA (Hemagglutinin)Neuraminidase
Beyond the preview
Go deeper on influenza virus split vaccine + BK-01 adjuvant.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on influenza virus split vaccine + BK-01 adjuvant.